News Numinus Wellness reports 12.6% sequential revenue growth to $6M The growth is attributed to a high number of clients at its psychedelic-assisted therapy clinics Natalia Buendia CalvilloJuly 17, 2023
Business Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials Natalia Buendia CalvilloDecember 10, 2021
Canada Numinus set to open Canada’s first psychedelics neurology centre The Vancouver based firm is acquiring the Neurology Centre of Toronto in a cash and stock deal Natalia Buendia CalvilloJuly 7, 2021
Canada Numinus to test natural psilocybin safety in Phase 1 trial Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy Jared GnamApril 27, 2021
The weed wire Numinus Wellness kicks off inaugural psilocybin mushroom crop Psychedelic mushrooms will be grown for research purposes Michelle GamageSeptember 25, 2020
Psychedelics Numinus licensed by Health Canada to extract and research psilocybin Extracting psilocybin from magic mushrooms will be cheaper than current method of creating synthetic compound for research, says company Michelle GamageJune 12, 2020
Medical and Pharmaceutical Canada could regulate psychedelic therapy within few years, bets company Numinus Wellness goes public on the prediction that regulation is coming Michelle GamageMay 22, 2020